SDS Optic develops and creates innovative solutions on the borderline of biochemistry, engineering and fibre optic technologies, that can be used in cancer diagnosis and treatment. The Company designed a revolutionary opto-biological methodology that allows instant study of cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. inPROBE detects presence and measures the concentration levels of HER+ cancer cells in breast tumours.
The SDS Optic team is working on a breakthrough technology based on rapid detection of test substances in the body, including cancer markers, with particular accuracy, the using laser beams and innovative components. At the end of the process, the reading is interpreted on the detector by means of an appropriate conversion algorithm, which gives the level of the compound tested (e.g. HER2 cancer marker) in numerical form.
Our technology is a breakthrough. We create inPROBE a tool for direct measurement of the HER2 marker. The use of a microsonde will save the patient pain and stress associated with a biopsy and waiting for the result. We want to save up to 30% of people diagnosed with cancer by 2030
